BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » market share

Market Share for Induced Pluripotent Stem Cell (iPSC) Research Products, by Product Category

June 25, 2015 By Cade Hildreth (CEO) Leave a Comment

Market research for iPSC research products

Since their discovery in 2006, induced pluripotent stem cells (iPSCs) have been commercialized in a number of different ways. iPSCs have been used as tools for drug development and discovery, for toxicology applications, in stem cell biobanking, in personalized medicine, and as research products.  While each of these commercial applications is important, this post specifically considers the use of iPSCs as research products – meaning, tools that scientists use in their labs for research purposes and applications.

Specifically, this post explores the breakdown of induced pluripotent stem cells (iPSCs) research products, by category. This analysis is intended to direct the decision-making of research supply companies by indicating where there is high market demand at this time.  (To learn about future directions for iPSCs, click here.)

[Read more…]

Filed Under: iPS Cells, Stem Cells Tagged With: induced pluripotent stem cells, iPSC, iPSC market share, iPSC research products, market research, market share

Mesenchymal Stem Cell (MSC) Products – The Cost of Winning Search Terms Online

May 20, 2015 By Cade Hildreth (CEO) Leave a Comment

Marketing Cost Analysis for “Mesenchymal Stem Cell”

Because Google now controls over 50% of online searches, it is the single best resource available for analyzing online search behavior within the mesenchymal stem cell (MSC) market.

Identifying the cost of winning search terms related to MSCs is an important analysis for company executives to conduct, because it allows for the planning of cost-effective Google AdWords campaigns and because it reveals existing levels of market competition for the sale of MSC products and services. [Read more…]

Filed Under: MSCs, Stem Cells Tagged With: competitive environment, market research, market share, marketing costs, mesenchymal stem cells, product development, stem cells

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    5段階中0の評価
    $297
  • U.S. Cord Blood Banking Survey Cord Blood Banking Survey of U.S. Parents [2017]
    5段階中0の評価
    $197
  • Exosome Companies 2020 Global Database of Exosome Companies
    5段階中0の評価
    $149 $97
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.